NCT03384823 - A Study of EDP-938 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

July 3, 2018

Study Completion Date

July 3, 2018

Conditions

RSV Infection

Interventions

DRUG

EDP-938

Subjects will receive either a single dose of EDP-938 on Day 1 only (SAD) or a single dose of EDP-938 starting on Day 1 through Day 7 (MAD).

DRUG

Placebo

placebo to match EDP-938

Trial Locations (1)

Pharmaceutical Research Associates, Inc.,, Lenexa